Uniretic

Uniretic is a brand name of hydrochlorothiazide/moexipril, approved by the FDA in the following formulation(s):

UNIRETIC (hydrochlorothiazide; moexipril hydrochloride - tablet; oral)

• 
  Manufacturer: UCB INC
  
  Approval date: June 27, 1997
  
  Strength(s): 12.5MG;7.5MG ^[AB], 25MG;15MG ^[RLD][AB]


• 
  Manufacturer: UCB INC
  
  Approval date: February 14, 2002
  
  Strength(s): 12.5MG;15MG ^[AB]

Has a generic version of Uniretic been approved?

Yes. The following products are equivalent to Uniretic:

MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (hydrochlorothiazide; moexipril hydrochloride tablet; oral)

• 
  Manufacturer: GLENMARK PHARMS
  
  Approval date: March 17, 2010
  
  Strength(s): 12.5MG;15MG ^[AB], 12.5MG;7.5MG ^[AB], 25MG;15MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: March 7, 2007
  
  Strength(s): 12.5MG;15MG ^[AB], 12.5MG;7.5MG ^[AB], 25MG;15MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Uniretic. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Uniretic.

See also...

• Uniretic Consumer Information (Wolters Kluwer)
• Uniretic Consumer Information (Cerner Multum)
• Uniretic Advanced Consumer Information (Micromedex)
• Hydrochlorothiazide/Moexipril Consumer Information (Wolters Kluwer)
• Moexipril/Hydrochlorothiazide Consumer Information (Wolters Kluwer)
• Hydrochlorothiazide and moexipril Consumer Information (Cerner Multum)
• Moexipril and hydrochlorothiazide Advanced Consumer Information (Micromedex)